Confirmatory Trials of Accelerated Approval Drugs — Will Imposing Fines Reduce Delays?
New England Journal of Medicine · 10.10.2024 · 391 (14) · 1273-1275
DOI: 10.1056/nejmp2400699 ↗Kurz gefasst
Fachartikel in der Zeitschrift New England Journal of Medicine, erschienen am 10.10.2024. Verfasst von C Joseph Ross Daval und 2 weiteren Autor:innen. Beteiligte Einrichtung: From the Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigh…. Hauptthemen laut MEDLINE: Clinical Trials as Topic, Drug Approval, United States Food and Drug Administration. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- From the Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston.
ORCID-Profile: Edward R Scheffer Cliff
Zitieren
APA
Daval, C. J. R., Kesselheim, A. S., & Cliff, E. R. S. (2024). Confirmatory Trials of Accelerated Approval Drugs — Will Imposing Fines Reduce Delays?. New England Journal of Medicine, 391(14), 1273-1275. https://doi.org/10.1056/nejmp2400699
Vancouver
Daval CJR, Kesselheim AS, Cliff ERS. Confirmatory Trials of Accelerated Approval Drugs — Will Imposing Fines Reduce Delays?. New England Journal of Medicine. 2024;391(14):1273-1275. doi:10.1056/nejmp2400699
BibTeX
@article{Daval2024,
author = {Daval, C Joseph Ross and Kesselheim, Aaron S and Cliff, Edward R Scheffer},
title = {Confirmatory Trials of Accelerated Approval Drugs — Will Imposing Fines Reduce Delays?},
journal = {New England Journal of Medicine},
year = {2024},
volume = {391},
number = {14},
pages = {1273--1275},
doi = {10.1056/nejmp2400699}
}
EUVIMED